Company intelligence / Profile preview

DSK BioPharma

Morrisville, North Carolina, United Statesdskbiopharma.com ↗

Ownership: Private
Development stage: Other

Overview

DSK BioPharma provides custom chemical synthesis services and supplies key intermediates, building blocks, metabolites, inhibitors, reference compounds, biochemicals and other high-purity organic compounds to pharmaceutical companies, biotech firms, academic labs and research organizations worldwide. The company specializes in complex multi-stage syntheses from milligram to kilogram scale. It does not have a proprietary drug development pipeline or clinical results.

Modalities: Small moleculeBiochemicalReference compoundScaffold
Industry: Drug Discovery Services

Partnerships

Collaborations with pharmaceutical manufacturers globallyCollaborations with academic institutions worldwide

Beyond the preview

Go deeper on DSK BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSK BioPharma.

Explore the full profile